Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Immunologic Abnormalities, Chronic Inflammation and Oxidative Stress in Chronic Kidney Disease

This study has been completed.
Sponsor:
Collaborator:
Beckman Laser Institute University of California Irvine
Information provided by (Responsible Party):
Beckman Laser Institute and Medical Center, University of California, Irvine
ClinicalTrials.gov Identifier:
NCT00793806
First received: November 14, 2008
Last updated: August 5, 2015
Last verified: August 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2012
  Primary Completion Date: March 2012 (Final data collection date for primary outcome measure)